Montelukast Prescribing at THE WHITEHOUSE CENTRE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
92
Total Quantity
1,743
NHS Cost
£146
vs National Avg
-86.6%
THE WHITEHOUSE CENTRE prescribed 92 items of Montelukast over the last 12 months at a cost of £146 to the NHS. This is 86.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
6
Jul 2026
10
Jul 2026
8
Jul 2026
8
Jul 2026
8
Jul 2026
10
Jul 2026
7
Jul 2026
7
Jul 2026
6
Jul 2026
10
Jul 2026
8
Jul 2026
4
Prescribing Details
| Total Items | 92 |
|---|---|
| Total Quantity | 1,743 |
| Total NHS Cost | £146 |
| Presentations | 4 different forms |
| vs National Average | -86.6% |
Montelukast Prescribing Comparison
| This practice | 92 items |
|---|---|
| National average per practice | 685 items |
| Difference | -86.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.